title: Cyclic opioid peptide agonists and antagonists obtained via ring-closing metathesis.
abstract: The opioid peptide H-Tyr-c[D-Cys-Phe-Phe-Cys]NH(2) cyclized via a methylene dithiother is a potent and selective mu opioid agonist (Przydial M.J. et al., J Peptide Res, 66, 2005, 255). Dicarba analogues of this peptide with Tyr, 2',6'-dimethyltyrosine (Dmt), 3-[2,6-dimethyl-4-hydroxyphenyl)propanoic acid (Dhp) or (2S)-2-methyl-3-(2,6-dimethyl-4-hydroxyphenyl)propanoic acid [(2S)-Mdp] in the 1-position were prepared. The peptides were synthesized on solid-phase by substituting d-allylglycine and (2S)-2-amino-5-hexenoic acid in position 2 and 5, respectively, followed by ring-closing metathesis. Mixtures of cis and trans isomers of the resulting olefinic peptides were obtained, and catalytic hydrogenation yielded the saturated -CH(2)-CH(2)- bridged peptides. All six Tyr(1)- and Dmt(1)-dicarba analogues retained high mu and delta opioid agonist potency and showed only slight or no preference for mu over delta receptors. As expected, the six Dhp(1)- and (2S)-Mdp(1)-dicarba analogues turned out to be mu opioid antagonists but, surprisingly, displayed a range of different efficacies (agonism, partial agonism or antagonism) at the delta receptor. The obtained results indicate that the mu versus delta receptor selectivity and the efficacy at the delta receptor of these cyclic peptides depend on distinct conformational characteristics of the 15-membered peptide ring structure, which may affect the spatial positioning of the exocyclic residue and of the Phe(3) and Phe(4) side chains.
authors.affiliation: Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal, Montreal, QC, Canada H2W 1R7.
authors.forename: Irena
authors.initials: I
authors.lastname: Berezowska
authors.forename: Carole
authors.initials: C
authors.lastname: Lemieux
authors.forename: Nga N
authors.initials: NN
authors.lastname: Chung
authors.forename: Brian C
authors.initials: BC
authors.lastname: Wilkes
authors.forename: Peter W
authors.initials: PW
authors.lastname: Schiller
mesh_terms: D000595:Amino Acid Sequence; D000701:Analgesics, Opioid / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D018847:Opioid Peptides / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D017465:Receptors, Opioid, delta / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism; D017450:Receptors, Opioid, mu / Q000819:agonists* / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D000701:Analgesics, Opioid; D018847:Opioid Peptides; D010456:Peptides, Cyclic; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu
references.citation: Br J Pharmacol. 1972 Dec;46(4):764-6
references.pmid: 4655272
references.citation: J Med Chem. 1987 Nov;30(11):2094-9
references.pmid: 2822930
references.citation: Br J Pharmacol Chemother. 1957 Mar;12(1):119-27
references.pmid: 13413163
references.citation: Proc Natl Acad Sci U S A. 1983 Oct;80(19):5871-4
references.pmid: 6310598
references.citation: Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
references.pmid: 4202581
references.citation: J Pept Res. 2005 Nov;66(5):255-62
references.pmid: 16218993
references.citation: J Med Chem. 1992 Feb 21;35(4):684-7
references.pmid: 1311764
references.citation: J Med Chem. 1982 Dec;25(12):1432-8
references.pmid: 6296388
references.citation: Life Sci. 1988;43(12):1013-20
references.pmid: 2845204
references.citation: Biochem Biophys Res Commun. 1978 Dec 29;85(4):1332-8
references.pmid: 217386
references.citation: Biochem Biophys Res Commun. 1981 Jul 30;101(2):337-43
references.pmid: 6272756
references.citation: J Med Chem. 2001 Sep 13;44(19):3048-53
references.pmid: 11543672
references.citation: J Med Chem. 1989 Mar;32(3):698-703
references.pmid: 2537427
references.citation: Biopolymers. 2005;80(2-3):325-31
references.pmid: 15614807
references.citation: Org Lett. 2003 Jan 9;5(1):47-9
references.pmid: 12509887
references.citation: Helv Chim Acta. 1974;57(5):1253-9
references.pmid: 4854571
references.citation: J Med Chem. 2007 Jun 28;50(13):3138-42
references.pmid: 17539621
references.citation: Eur J Pharmacol. 1979 Sep 1;58(1):11-8
references.pmid: 499333
references.citation: Acta Biochim Pol. 2006;53(1):73-6
references.pmid: 16496038
references.citation: Org Lett. 1999 Sep 23;1(6):953-6
references.pmid: 10823227
references.citation: Br J Pharmacol Chemother. 1968 Jun;33(2):266-76
references.pmid: 5664147
references.citation: J Med Chem. 2007 Mar 22;50(6):1414-7
references.pmid: 17315860